Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksIQ-AI Share News (IQAI)

Share Price Information for IQ-AI (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.845
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (6.098%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.845
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ingenta trades in line; Triple Point Social NAV up

Fri, 17th May 2024 17:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Condor Gold PLC - Gold exploration company with operations focused on Nicaragua - Pretax loss narrows 33% to GBP1.7 million in 2023 from GBP2.5 million in 2022. The firm says: "The company remains convinced that the 587 square kilometres La India project is a major gold district with the potential for significant future discoveries. Condor's geologists have identified two major north-northwest-striking mineralised basement feeder zones traversing the project, the 'La India Corridor', which hosts 90% of Condor's gold mineral resource and the 'Andrea Los Limones Corridor'. Numerous geophysics, soil geochemistry and surface rock chips indicate the possibility for further mineralisation along strike."

----------

Ethernity Networks Ltd - Lod, Israel-based supplier of data processing semiconductor technology for networking appliances - Enters into structured investment deed with New Technology Capital Group LLC. New Tech will invest GBP800,000 into Ethernity, expected next week. Relating to this, Ethernity will issue 40.0 million new shares to New Tech. Ethernity Chief Executive Officer David Levi says: "We have strong confidence in the company's future prospects, anticipating a rise in the company's value as we embark on strategic initiatives."

----------

Fulcrum Metals PLC - mineral explorer in Canada - Says it has been fully engaged in working towards the completion of the sale of its uranium portfolio in Saskatchewan to Terra Balcanica Resources Corp. CEO Ryan Mee says: "Certain steps under that process have, unfortunately, taken longer than anticipated, but we are confident that the acquisition will be completed by the extended back stop date of 15 June 2024."

----------

Ingenta PLC - Oxford, England-based provider of software and services to the publishing industry - Says it intends to release its 2023 results this month, noting that underlying trading performance is expected to be as it announced in January. "Current trading continues to be in line with management expectations, with cash flow ahead of budget and the company on track to deliver a further year of solid progress," Ingenta says.

----------

IQ-AI Ltd - medical services firm - Notes that its subsidiary Imaging Biometrics announces the successful deployment of its software at Insel Gruppe AG in Bern, Switzerland. Imaging Biometrics CEO Michael Schmainda says: "The installation at Insel Gruppe AG allows them full access to our comprehensive suite of applications. We are excited about this collaboration and are committed to supporting Insel Gruppe AG as they set new standards in patient care."

----------

Oracle Power PLC - energy projects developer - Says two drill rigs are contracted to start drilling at the Northern Zone gold project in Western Australia next week. CEO Naheed Memon says: "We have a very large gold exploration target here, which is centred around a large porphyry gold system that has been proven to be over 100 metres in true width."

----------

Pathfinder Minerals PLC - AIM-listed cash shell seeking reverse takeover - Says on Thursday received outstanding balance of GBP30,000 from the subscriber regarding a subscription of around GBP1.3 million. It adds that there is no outstanding balance due from the subscriber.

----------

Sivota PLC - investor in later-stage Israeli technology firms - Says that negotiations with an online technology platform have terminated after the signing of a non-binding term sheet back in January. Back then, Sivota said it intended to raise about GBP250,000 via share placing. With the termination, the signing of a definitive agreement will not proceed. "The company remains committed to exploring further merger & acquisition activity and is evaluating its pipeline opportunities," Sivota says.

----------

Technology Minerals PLC - London-based battery metals and recycling firm - Gives notice to Atlas Capital Market LLC of a draw down of GBP600,000 to be issued on May 30. "Use of the new funds rawn will include continued support of the scale up in operations at Recyclus' lithium-ion plant in Wolverhampton, ahead of the proposed acquisition of the shares not held by the company, as previously announced," the company explains. Technology holds a stake of around 48.35% in Recyclus Group Ltd.

----------

Triple Point Social Housing REIT PLC - London-base property investor - Appoints Akur Ltd to conduct independent review of investment management arrangements. Separately, reports net asset value per share of 114.15 pence as at March 31, up 0.3% from 113.76p at December 31.

----------

UK Oil & Gas PLC - oil and gas with assets in UK and Turkey - Says regarding a funding facility announced in June 2023, principal balance stands at about GBP370,000 of GBP2 million gross first cash sum received.

----------

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Feb 2025 19:22

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis

IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford Analysis Ltd. The amendment adds IB Nimble, IB ASL, IB FTB, and IB FTB Express to the agreement, allowing Blackford to also sell these products to their global client base. Acquired by Bayer in early 2023, Blackford operates in the healthcare AI platform and solutions sphere.

Read more
22 Jan 2025 17:10

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities

IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way in Food & Drug Administration approvals for AI-enabled products as the FDA has increased efforts to keep pace with the advancements in AI technology. The company believes its subsidiary, Imaging Biometrics LLC, is in a unique position to lead this transformation for neuro-oncology in 2025 and beyond. Points to the imminent release of the new version of IB Clinic; its FDA-cleared suite of quantitative imaging solutions will include the incorporation of an AI model, which will greatly improve diagnostic accuracy and speed. In addition, notes the first half of 2025 should mark the next release of IB Nimble with the functionality to view IB's AI-generated images and other images within the mobile app. Also, in 2025 we anticipate releasing a new product leveraging arterial spin labelling.

Read more
14 Oct 2024 10:05

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown

IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and treatment of patients - AIM-listed technology investor Braveheart Investment Group PLC buys a nearly 30% stake in IQ-AI from Braveheart Chief Executive Officer Trevor Brown. Braveheart buys 45.8 million IQ-AI shares from Brown at 1.1 pence per share, worth GBP503,372, and another 19.7 million shares owned by Brown's children at the same price, worth GBP216,203. The two purchases give Braveheart a 29.5% stake in IQ-AI. Braveheart on Friday says the related-party transaction is approved by its independent shareholders because the IQ-AI business fits Braveheart's investment strategy and the purchase is at "an attractive entry price".

Read more
16 Aug 2024 20:40

TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Alliance News:

Read more
25 Jun 2024 11:56

IN BRIEF: IQ-AI subsidiary opens expanded access programme

IQ-AI Ltd - London-based medical services company - US-based subsidiary Imaging Biometrics LLC says that US Food & Drug Administration has approved an expanded access programme for oral gallium maltolate. This EAP will run in parallel with the current phase 1 clinical trial being conducted at the Medical College of Wisconsin. Explains that "As the phase 1 trial concludes this fall and while the data is being compiled, eligible patients in the US will have the option of participating in the EAP."

Read more
14 Jun 2024 14:32

IQ-AI team begins defining phase 2 protocol for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Friday said the clinical team has started a phase 2 protocol for its oncology-focused drug oral gallium maltolate, which could be a therapeutic agent for cancer.

Read more
23 May 2024 21:08

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
20 May 2024 11:16

IQ-AI subsidiary gets second FDA rare paediatric disease designation

(Alliance News) - IQ-AI Ltd on Monday said its subsidiary, Imaging Biometrics LLC, received a second rare paediatric disease designation by the US Food & Drug Administration for its IB-003 lead drug candidate oral gallium maltolate.

Read more
10 May 2024 15:14

IQ-AI subsidiary gets rare paediatric disease designation FDA

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary, Imaging Biometrics LLC, has been granted rare paediatric disease designation by the US Food & Drug Administration for its lead drug candidate, IB-003, or gallium maltolate for the treatment of ATRT.

Read more
2 May 2024 15:45

EARNINGS AND TRADING: Trident Royalties swings to profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more
10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

Read more

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.